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Abstract We amplified the coding region DNA sequence from a
rat renal pICln cDNA by PCR and expressed the protein in
Escherichia coli cells. The cells were exposed to hypotonic
conditions followed by spreading them onto LB plates for
subsequent colony survival assay. The present study demon-
strated that the cells expressing pICln exhibit a strong resistance
to hypotonic stress. Moreover, the resistance was specifically
inhibited by extracellular ATP and some anion channel
inhibitors. These findings indicate that the expression of pICln
directly confers tolerance to hypotonic stress, and pICln is
concluded to be an important molecule for cell-volume regula-
tion.
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1. Introduction
It is essential for every cell to maintain a constant cell
volume [1,2]. Although the phenomenon of regulatory volume
decrease (RVD), by which a swollen cell loses solute and
water to restore its constant volume, has been observed for
decades, the molecular mechanism responsible for the volume
control is not well-known [3].
As one of the possible candidates for a volume-regulated
anion channel, in 1992, Paulmichl et al. [4] reported the clon-
ing of a cDNA that codes a 235-amino acids protein termed
pICln (I = current, Cl = chloride, n = nucleotide-sensitive) from
MDCK cells. When overexpressed in Xenopus oocytes, pICln
gives rise to an outwardly rectifying chloride conductance
displaying a feature consistent with the swelling-induced
chloride current (ICl:swell) seen in several cells [5^8]. pICln was
initially proposed as a membrane-spanning Cl3 channel with
an antiparallel L-barrel after several analyses. Shortly after the
publication of these studies, in 1994, Krapivinsky et al. [9]
demonstrated that abundantly cytoplasmic localization and
soluble characteristics of this protein are unexpected for an
ion channel; pICln was therefore concluded to be a Cl3 chan-
nel regulator but a channel-forming protein itself. As another
possibility, in 1996, Strange et al.[10] proposed an ‘anchor3
insertion channel’ model for pICln. Based on their specula-
tions, cell osmotic swelling might release pICln from its cyto-
solic binding site, allowing the protein to insert spontaneously
into the cell membrane to form a channel. However, pICln was
recently described to be neither a channel itself by Buyse et al.
[11] nor a regulator of a volume-regulated anion channel
(VRAC) by Voets et al. [12]. At present, the dispute over
channel vs. regulator surrounding pICln is seemingly shifting
to over whether it has anything at all to do with ICl:swell which
is critical to cell-volume regulation.
Much controversy over pICln still remains unresolved, and
the function of pICln has yet to be discovered [13]. A close link
between pICln and ICl:swell had been reported by experiments in
which the ICl:swell was inhibited after treatment of cells with
antisense oligonucleotides or anti-pICln monoclonal antibodies
[14,9]. More recently, this link was also con¢rmed in the epi-
thelium by Chen et al. [15]. Importantly, we previously ob-
served that pICln is predominantly present on the lumenal
surface membranes of the distal tubules, where it faces the
lowest osmolality in the nephrons; thus the function of
pICln was suggested to be the protection of the cells from
osmo-swelling against intra-tubular hypotonic solution [16].
It is of interest to ask whether pICln can confer hypotonic
resistance. In the present study, we subcloned and expressed
pICln in Escherichia coli cells. Using the cells, hypotonic tol-
erances were investigated.
2. Materials and methods
2.1. Subcloning of pICln gene into an expression vector
The gene for pICln was ampli¢ed from rat renal pICln cDNA
(DDBJ/GenBank/EMBL databases, accession numberD13985) which
was kindly given by Dr. Takaaki Abe [17]. The selected primers were
5P-CGCCGGTACCAATGAGCTTCCTCAAAAG-3P with a KpnI site
(including start codon) and 5P-CGCCTCTAGATCAGTGGTCAAC-
GTCTGC-3P with a XbaI site (including stop codon). The reaction
was carried out with KOD DNA Polymerase Kit (Toyobo, Osaka,
Japan) in a Gene Amp 2400-R PCR System (Perkin-Elmer, CA, USA)
and performed according to the following program: an initial cycle of
94‡C (30 s), 50‡C (30 s), and 74‡C (1 min) was followed by 25 cycles
of 98‡C (15 s), 65‡C (2 s), and 74‡C (30 s).
The PCR product was treated with phenol extraction, followed by
digestion with restriction endonucleases KpnI and XbaI (New England
Biolabs). The corresponding digestion was applied to expression plas-
mid pThioHis (Invitrogen, CA, USA). Both fragments were run on an
1% agarose gel and isolated with the GeneClean II Kit (Bio 101, CA,
USA). The pICln gene fragment was then subcloned into pThioHis by
T4 DNA ligase reaction (Boehringer-Mannheim) to obtain pICln-ex-
pressing plasmid. After transformation in E. coli cells and plasmid
preparation (Qiagen), the correct construction was con¢rmed by re-
digestion with KpnI and XbaI.
2.2. Expression of tag-pICln in E. coli
After transformation of the expression vector in E. coli TOP10
(Invitrogen, CA, USA), a single colony was inoculated into 10 ml
LB medium (1% tryptone and 0.5% yeast extract, both from Gibco
BRL; 1% NaCl, pH 7.0) containing ampicillin (100 mg/l). After in-
cubation for 8 h at 37‡C, the culture was transferred to 1 l of the same
medium in a 3-l £ask. Incubation was continued in a shaking incu-
bator at 37‡C until an optical density of 0.5 at 550 nm was reached.
At this point, isopropyl-L-D-thiogalactopyranoside (IPTG) was added
to a ¢nal concentration of 1 mM. After shaking for di¡erent times,
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cells were used for protein-expression checking with SDS-PAGE, for
hypotonic tolerance study (2 h) or for pICln puri¢cation (8 h).
As the control, the plasmid pThioHis (Invitrogen, CA, USA) was
used to express an only tag peptide (thioredoxin) by the same way.
The expression of the tag peptide was con¢rmed with immunoblot
assay using a speci¢c anti-thioredoxin antibody (Invitrogen, CA,
USA).
2.3. Puri¢cation of tag-pICln and N-terminal amino acid sequencing
All operations of the puri¢cation were carried out at 0^4‡C. pICln-
expressing cells were harvested by centrifugation (Tomy SRX-201,
10 000Ug, 15 min) after 8 h of IPTG induction, and were resuspended
in 3 ml of 10 mM Tris-HCl bu¡er (0.1% Triton X-100, pH 8.0) per
gram of cells (wet weight). Cell suspension was sonicated on ice with
two or three 10 s bursts at 150 W, the lysate frozen by liquid nitrogen,
and then quickly thawed at 37‡C. The treatments were repeated three
times. The soluble fraction was obtained by centrifugation (22 000Ug,
20 min) of cell lysate. The soluble lysate was applied to an anion
exchanger DE52 (Whatman, UK) column which had previously
been equilibrated with 10 mM Tris-HCl bu¡er containing 0.5 mM
EDTA, 0.1% Triton X-100, pH 8.0. After washing the column with
the equilibrating bu¡er, proteins were eluted with a linear gradient of
0^0.5 M NaCl in the bu¡er. All fractions were analyzed by SDS-
PAGE. The 50 kDa protein-enriched fractions were collected and
dialyzed overnight against 10 mM potassium phosphate bu¡er, pH
7.0. The sample was applied to a hydroxyapatite (Wako, Tokyo,
Japan) column pre-equilibrated with the same bu¡er, and eluted
with a linear gradient of 10^500 mM potassium phosphate bu¡er,
pH 7.0. The 50 kDa protein fractions were collected, and digested
with lysylendopeptidase (EC 3.4.21.50, Wako, Osaka, Japan). The
resulting peptides were separate on a reverse-phase column of Wako-
pak (Wakosil 5C18) connected with an HPLC apparatus (Pharmacia
LKB, Sweden).
N-terminal sequence analysis of peptides was performed on an Ap-
plied Biosystem 491 Procise Sequencer (Perkin-Elmer, CA, USA) with
standard methods.
2.4. Electrophoresis and immunoblot
Aliquots (20 Wg proteins) of samples were subjected to SDS-PAGE
by the method of Laemmli [18]. Coomassie brilliant blue R-250 (CBB)
was used for the staining of the proteins. Western blot assay was
performed by the method of Towbin et al. [19] with slight modi¢ca-
tions [20]. Protein concentrations were determined by Lowry’s method
[21]. Anti-tag peptide (thioredoxin) antibody (Invitrogen, CA, USA;
dilution: U1000) and goat anti-rabbit IgG conjugated with horserad-
ish peroxidase (Bio-Rad, Richmond, CA, USA) (dilution: U1000)
were used. The substrate was 3,3-diaminobenzidine tetrahydrochlo-
ride.
2.5. Hypotonic tolerance assay
Two types of E. coli cells harboring the plasmid with or without
pICln genes were grown in LB medium as described above. After
IPTG induction, incubations were continued at 37‡C for 2 h. 100 Wl
of each culture was transferred to 100 ml distilled water (dH2O) to
reach a harsh hypotonic stress (0.17 mM of ¢nal NaCl concentration).
Three samples from each hypotonic suspension were removed into
5 ml of 0.7% TOP agarose (10 g tryptone, 5 g NaCl, 7 g agarose
per liter) at 15, 30, and 60 min, followed by spreading them onto LB
plus ampicillin plates for colony survival assay.
Colony survival assay was performed according to previously de-
scribed methods [22,23]. The spreading plates were incubated over-
night at 37‡C before counting the number of single colonies (cell
survival number) on each plate. The colony-forming units (CFU)
were calculated, and the hypotonic tolerance was re£ected by each
‘survival rate’ (% of total cells) as shown: Rsurvival = CFUhypo/
CFUnonÿhypoU100%. The dH2O containing 171 mM NaCl as the
same as in normal LB medium was used for the control
(CFUnonÿhypo).
2.6. E¡ects of ATP and anion channel inhibitors on E. coli with
the hypotonic tolerance
Aliquots (10 Wl) of pICln-expressing E. coli culture after 2 h of IPTG
induction were added to 10 ml of distilled water pre-mixed with ATP
or each inhibitor at di¡erent ¢nal concentrations. After 30 min, three
aliquots of each cells suspension were mixed with 5 ml of 0.7% TOP
agarose and spread onto LB plates followed by a colony survival
assay as described above.
3. Results and discussion
3.1. Construction of pICln-expressing vector
A double-strand pICln gene encoding a 236 amino acid se-
quence was ampli¢ed from rat renal cDNA (see Fig. 1A) by
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Fig. 1. Construction of pICln-expressing plasmid. A: Alignment of rat renal pICln cDNA (see [17]). The pICln coding region was ampli¢ed by
PCR using the two primers (p1 and p2). The underlines (I^IV) are putative trans-membrane domains. B: The correct construction was con-
¢rmed on agarose electrophoresis. Ampli¢ed pICln gene was inserted into an expression plasmid. The constructed circular plasmid (lane 1) was
linearized with KpnI (lane 2), or with KpnI and XbaI (lane 3). The arrow indicates inserted pICln genes.
G.Z. Tao et al./FEBS Letters 434 (1998) 28^32 29
PCR. The PCR product was a single band of 732 bp. After
digestion with two restriction enzymes, the pICln gene frag-
ment was constructed with sticky ends (5P-end: KpnI; 3P-
end: XbaI).
Plasmid pThioHis (4.4 kb) carries a 357 nucleotide frag-
ment encoding a tag-peptide (thioredoxin) followed by a pol-
ylinker. The pICln was inserted between the KpnI and XbaI
sites. The correct insertion of the pICln gene was con¢rmed by
a re-cut of the constructed plasmid with the restriction en-
zymes. As shown in Fig. 1B, the constructed circular pICln-
expressing plasmid (lane 1) was linearized by KpnI (lane 2) or
was digested into an insert and a plasmid fragment bands
(lane 3) by KpnI plus XbaI.
3.2. Expression of pICln in E. coli cells
After transformation of the above-mentioned plasmid with
or without the pICln gene in the E. coli cells, as shown in Fig.
2A CBB, in comparison with wild-type cells (lane 1), a 15.6
kDa protein was expressed in the control cells which harbor
only the plasmid (lane 2), and a 50 kDa protein was expressed
in the cells harboring a plasmid with the pICln gene (lane 3).
On an immunoblot (Fig. 2A Blot), the protein band (lane 2)
migrating at 15.6 kDa was speci¢cally immunostained with an
antibody against the tag-peptide (thioredoxin). This con¢rmed
the expression of tag-peptide (15.6 kDa band) in control E.
coli cells.
To further verify whether pICln is contained in the 50 kDa
fusion protein, we substantially puri¢ed the 50 kDa fusion
protein from the cell lysate by two column chromatographies
(Fig. 2B). The puri¢ed 50 kDa protein was digested into pep-
tide fragments with lysylendopeptidase, followed by N-termi-
nal amino acid sequence analysis. As shown in Fig. 2B (lower
pattern), the two analyzed partial sequences are 100% consist-
ent with amino acids 31^65 and 119^138 of the pICln sequence
(see Fig. 1A).
3.3. Hypotonic tolerance observed in the pICln-expressing
E. coli cells
Expression of exogenous proteins in E. coli cells to explore
its function is a widely used method [22^24], and no pICln
homologue is found in E. coli genomic DNA by a homology
search. On exposure of E. coli cells to hypotonic conditions,
some cells will be osmotically killed by cell lysis, and the
number of remaining cells can be checked by a colony survival
assay.
The survival rates (% of total cells) under hypotonic stress
were compared at di¡erent times between pICln-expressing E.
coli and its control cells in the present study. Surprisingly, as
shown in Fig. 3, the survival rates of pICln-expressing cells
were signi¢cantly higher than that of control cells at the
time points 30 min and 60 min. In addition, after hypotonic
stress, obvious cell lysis was observed on control cell glass
slides in comparison with that of pICln-expressing cells by
optical microscopy (data not shown). The expression patterns
of cellular proteins are not apparently di¡erent between pICln-
expressing cells and control cells (see Fig. 2A), with the ex-
ception of the 15.6 kDa tag and 50 kDa tag-pICln fusion
proteins. These results indicate that the expression of pICln
in the cells directly contributed to the strong tolerance to
hypotonic stress.
3.4. Speci¢c inhibition of the hypotonic tolerance by
extracellular ATP
pICln was initially cloned as a nucleotide-sensitive Cl3 chan-
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Fig. 2. Expression of pICln and con¢rmation with amino acid se-
quencing. A: 50 kDa fusion protein and tag peptide were expressed
in E. coli cells. The cells transformed with pICln-expressing plasmid
or with the plasmid only were induced to express the proteins by
adding IPTG to the cultures. Samples were taken after 2 h of IPTG
induction, and subjected to 12.5% SDS-PAGE followed by staining
with CBB (CBB), or immunoblotting using a speci¢c anti-tag pep-
tide antibody (Blot). Samples were lysates from E. coli cells of wild-
type (lane 1), only plasmid (lane 2), and plasmid with pICln gene
(lane 3). The arrows are indicating tag-peptide (15.6 kDa). B: Puri-
¢cation and amino acid sequencing. The 50 kDa protein was puri-
¢ed from the pICln-expressing cell lysate by two column chromatog-
rapies. SDS-PAGE of the puri¢cation was stained with CBB.
Samples were from cell lysate (lane 1), DE52 column (lane 2), hy-
droxyapatite column (lane 3). The puri¢ed tag-pICln (50 kDa) was
digested into peptide fragments followed by amino acid sequencing.
The analyzed two sequences are 100% consistence with amino acids
31^65 and 119^138 of the pICln sequence (see Fig. 1).
Fig. 3. The pICln-expressing E. coli cells exhibit a strong hypotonic
tolerance. pICln-expressing cells and the control cells were removed
into hypotonic solution after 2 h IPTG induction. At 15, 30, and 60
min, three aliquots of each cell suspension were spread onto LB
plates, and incubated overnight at 37‡C followed by colony survival
assay. The colony survival rates re£ecting their hypo-tolerance were
compared between the tag-pICln expressing cells (b) and tag only ex-
pressing cells (R) (n = 3; **P6 0.01).
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nel, and its outwardly rectifying Cl3 current induced by ex-
pression of this protein in oocytes was well-known to be in-
hibited by treatment of the cell with nucleotides including
ATP [4]. To con¢rm the link between hypo-tolerance and
expression of pICln, inhibition experiments were performed
with a series of pICln-sensitive extracellular ATPs. As shown
in Fig. 4, a speci¢c inhibition of ATP at 1035^1034 M on the
survival rate of pICln-expressing cells was observed, while at
the same range of ATP concentrations, the survival rates of
control cells were not signi¢cantly a¡ected. The results indi-
rectly indicate that the hypotonic tolerance was due to the
expression of pICln in the E. coli cells. A higher concentration
of ATP (s 1033 M) could also decrease the survival rate of
control cells (data not shown). The nucleotide-binding site has
been proposed to be the GXGXG motif localized at the out-
side of the pICln channel pore [4]. Recently, however, Voets
et al. [12] reported that this GXGXG motif is not important
for the sensitivity of the ICln to nucleotides by electrophysio-
logical experiments after injection of a mutant cRNA
(GXGXGCAXAXA) into Xenopus oocytes. The mechanism
of how extracellular ATP inhibits the hypo-tolerance or the
current (ICln) is still unknown.
3.5. E¡ects of anion channel inhibitor drugs on the
hypo-tolerance
The Cl3 current (ICl) induced by expression of pICln in
Xenopus oocytes was blocked with some channel inhibitors
including NPPB or DIDS [4,11,12]. As shown in Fig. 5, the
survival rates of pICln-expressing cells were also blocked by
three inhibitor drugs, while the control cells were not signi¢-
cantly a¡ected. The inhibitory sequence for the hypotonic
tolerance is DIDSsNBBPvDPC. These results indicate
that the hypotonic tolerance is closely linked to the activation
of an anion channel. Although the pICln was also found in
membrane fractions (data not shown), it is still uncertain
whether the expressed pICln is inserted into the membrane to
form the anion channel as proposed by Paulmichl et al. [4] or
Strange et al. [10]. However, the present results explain that
pICln can activate the endogenous anion channel originally
existing in the E. coli membrane to restore the hypo-induced
swollen cells.
3.6. Conclusions
We have unambiguously shown that E. coli cells expressing
rat pICln exhibit a strong tolerance to hypotonic stress. The
tolerance was sensitive to extracellular ATP or some anion
channel blockers. Taken together, the present results and
our previous data showing that pICln is predominantly local-
ized at the membranes of the distal tubules where it is exposed
to the most diluted intra-tubular solution, pICln is concluded
to play a critical role in cell-volume regulation through an
anion channel.
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Fig. 5. E¡ects of channel blocker drugs on the hypotonic tolerance.
pICln-expressing cells and the control cells were transferred to the
hypotonic solution pre-mixed with absence or presence of channel
blocker drugs at di¡erent concentrations. After 30 min of exposure
to hypotonic stress, three aliquots of each cell suspension were
spread onto LB plates for subsequent colony survival assay. The
E. coli cells survival rates were compared between the two hypoton-
ic solutions with and without the drugs (n = 3; *P6 0.05;
**P6 0.01).
Fig. 4. Speci¢c inhibition of the hypotonic tolerance by extracellular
ATP. E. coli cells after 2 h IPTG induction were transferred to hy-
potonic solution pre-mixed with absence or presence of ATP at dif-
ferent concentrations. After 30 min of exposure to the hypotonic
conditions, three aliquots of each cell suspension were taken and
spread onto LB plates for a subsequent colony survival assay. The
survival rates of E. coli in each concentration of ATP were com-
pared with that of non-ATP treatment (n = 3; **P6 0.01). The tag-
pICln-expressing cells (a) ; tag-expressing cells (j).
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